Osteoarthritis

In this late-breaking research shown at ACR 2023, TLC599 injection led to benefits in patients with a single injection and further benefits with a second.

Osteoporosis is estimated to affect 595 million patients worldwide, representing a 132% increase in total cases since 1990.

Patients identified areas of confusion in data presentation and suggested educational support to better engage with the information provided.

The guidelines were created using a panel of rheumatologists, orthopedic surgeons, and patients.

A retrospective analysis comparing propensity score matched metformin users against sulfonylurea users, results of the study indicate metformin use was associated with a 24% reduction in relative risk of developing osteoarthritis.

The multicenter superiority trial evaluated patients with diagnosed knee osteoarthritis and a history of pain and decreased knee function using patient-tailored exercise programs.

Vitamin D supplements are often recommended for the improvement of bone health, but investigators say the data are unclear whether they prevent fractures.

The complete ACR manuscript is available to elaborate on the earlier summary of antirheumatic medication for patients who are undergoing total hip or total knee anthroplasty.

Investigators address the need for understanding surrounding the relationship between poor bone health and patients who are hemophilia carriers and those with von Willebrand disease.

Authors of the study on PRP in knee osteoarthritis addressed the concerns shared by physicians in response to the method of their research.

The results lead investigators to question the usefulness of prehabilitation before total knee replacement to improve functional outcomes in patients with osteoarthritis.

Investigators examined the effect that pulsed low-intensity ultrasonography had on symptom relief and tibiofemoral articular cartilage thickness among patients with knee osteoarthritis.

Aspartyl-alanyl-diketopiperazine (Ampion), an intra-articular injection, works to regulate immune responses that are connected to pain, inflammation, and joint damage in patients with osteoarthritis of the knee.

New data show that even though physical therapy may be the more expensive treatment for knee osteoarthritis, it’s more effective than intra-articular glucocorticoid injection.

Investigators closely examine the differences between neuromuscular changes associated with normal aging and those associated with age-related disorders and how they affect individuals with knee osteoarthritis.

Despite the increasing trend of PRP in knee osteoarthritis, most clinical guidelines do not recommend it due to a lack of evidence on its efficacy.

Data show no significant improvement in pain, function and alignment scores over 26 weeks in the PRP injection group, compared to placebo.

Research suggests that men and women of all ages in mainland China recorded similar results of untreated osteoporosis and vertebral and clinical fractures, all of which are becoming more prevalent over time.

New findings show patients with osteoarthritis and rheumatoid arthritis share comorbidities that contribute to an increased likelihood of frailty, especially in older populations.

The risk was generally did not depend on whether the initial fracture was deemed traumatic or nontraumatic.

The therapy was generally well-tolerated and offered substantial pain relief in patients.

A new study finds educational video and booklets result in increased levels of patient knowledge in managing knee osteoarthritis, particularly among Spanish-speaking and less educated patients.

Improvements for pain did not sustain at the 12 month follow-up.

An international survey shows an increase in telemedicine, but a decrease in out-patient care.

Increasing dosage of mometasone is associated with elevated risk of osteoporosis and major osteoporotic fractures.

The VELYS Robotic-Assisted solution will be used in conjunction with the VELYS Digital Surgery Platform.

Just 2% of observed older men to experience an indicative fracture received a diagnosis and treatment for osteoporosis over a four-year period.

An expert discusses the state of screening, diagnosing, and treating osteoarthritis and osteoporosis.

Despite negative trial resutls, the data support the posibility of tapering off NSAIDs and the plausibility of self-management approaches like CBT.